Literature DB >> 29098721

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

Massimo Gentile1, Tait D Shanafelt2,3, Francesca R Mauro4, Luca Laurenti5, Davide Rossi6, Stefano Molica7, Iolanda Vincelli8, Giovanna Cutrona9, Giuseppina Uccello1, Sara Pepe4, Ernesto Vigna1, Giovanni Tripepi10, Kari G Chaffee11, Sameer A Parikh2, Sabrina Bossio12, Anna Grazia Recchia12, Idanna Innocenti5, Raffaella Pasquale5, Antonino Neri13, Manlio Ferrarini14, Gianluca Gaidano15,16, Robin Foà4, Fortunato Morabito12.   

Abstract

Mesh：

Year:  2017        PMID： 29098721     DOI： 10.1002/ajh.24960

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

Review 1.  On the architecture of translational research designed to control chronic lymphocytic leukemia.

Authors:  Michael Hallek
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

2.  The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index.

Authors:  Carolina Muñoz-Novas; María Poza-Santaella; Isabel González-Gascón Y Marín; María Hernández-Sánchez; Ana-Eugenia Rodríguez-Vicente; María-Stefania Infante; Cecilia Heras; María-Ángeles Foncillas; Karen Marín; Jesús-María Hernández-Rivas; José-Ángel Hernández
Journal:  Biomed Res Int       Date:  2018-03-15       Impact factor: 3.411

3.  First-line therapy in chronic lymphocytic leukemia: a Swedish nation-wide real-world study on 1053 consecutive patients treated between 2007 and 2013.

Authors:  Sandra Eketorp Sylvan; Anna Asklid; Hemming Johansson; Jenny Klintman; Jenny Bjellvi; Staffan Tolvgård; Eva Kimby; Stefan Norin; Per-Ola Andersson; Claes Karlsson; Karin Karlsson; Birgitta Lauri; Mattias Mattsson; Anna Bergendahl Sandstedt; Maria Strandberg; Anders Österborg; Lotta Hansson
Journal:  Haematologica       Date:  2018-11-22       Impact factor: 9.941

4.  Prognostic and Therapeutic Value of Apolipoprotein A and a New Risk Scoring System Based on Apolipoprotein A and Adenosine Deaminase in Chronic Lymphocytic Leukemia.

Authors:  Xiaoya Yun; Xiang Sun; Xinting Hu; Huimin Zhang; Zixun Yin; Xin Zhang; Ming Liu; Ya Zhang; Xin Wang
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

5.  Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.

Authors:  Nina Kreuzberger; Johanna Aag Damen; Marialena Trivella; Lise J Estcourt; Angela Aldin; Lisa Umlauff; Maria Dla Vazquez-Montes; Robert Wolff; Karel Gm Moons; Ina Monsef; Farid Foroutan; Karl-Anton Kreuzer; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2020-07-31

6.  [Prognostic significance of CLL-IPI for Chinese patients with chronic lymphocytic leukemia].

Authors:  H Y Zhu; L Wang; J Qiao; Y X Zou; Y Xia; W Wu; L Cao; J H Liang; L Fan; W Xu; J Y Li
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-05-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.